“The consumption” was a popular name for tuberculosis, the chronic bacterial infection that slowly wasted its victims from the inside out, leaving them pale, thin, feverish, and coughing blood. The name stuck because the disease seemed to literally consume the body. Tuberculosis has an extraordinarily long history with our species, stretching back at least 70,000 years, and its story winds through ancient civilizations, romantic-era literature, grim sanatoriums, groundbreaking science, and a modern global crisis that remains far from resolved.
A Disease as Old as Humanity
Tuberculosis is not a disease of civilization so much as a disease of being human. The bacterium behind it, Mycobacterium tuberculosis, is an obligate human pathogen, meaning it evolved to live in us and only us. For a long time, scientists assumed humans caught TB from cattle during the Neolithic period, when people first started domesticating animals. But genetic and biomolecular studies have upended that story. Analysis of the Mycobacterium tuberculosis complex shows the bacterium emerged roughly 70,000 years ago in Africa and spread alongside anatomically modern humans as they migrated out of the continent.1PubMed Central. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans TB did not jump from animals to people. People carried it with them everywhere they went.
This long shared history means the bacterium and the human immune system have been locked in an evolutionary arms race for millennia. Mycobacterium tuberculosis adapted to both low-density hunter-gatherer populations and the crowded settlements that came later, then expanded dramatically when Neolithic farming pushed human population densities higher.2PubMed Central. Co-evolution of Mycobacterium tuberculosis and Homo sapiens Humans, meanwhile, developed genetic resistance, though the specifics remain poorly understood. What is clear is that TB has been shaping human biology, and vice versa, for far longer than any other infectious disease we commonly think about.
Physical evidence of the disease appears in skeletal remains from Neolithic Europe, ancient Egypt, and pre-Columbian America. The hallmark skeletal sign is Pott’s disease, a collapse of the vertebrae caused by spinal TB, though ancient DNA techniques have also identified the bacterium in mummified tissue and bones that show no obvious lesions at all.3PubMed. Paleomicrobiology of Human Tuberculosis The disease was present across continents long before anyone had a name for it, let alone a cure.
Why It Was Called “the Consumption”
The term “consumption” entered English in the Middle Ages and became the dominant name for the disease across Europe by the 17th century. It described exactly what people saw: a patient who grew thinner and weaker week by week, as if something invisible were eating them from within. The Latin root, consumere, means to devour or waste away. Before anyone understood bacteria, consumption was treated as a condition rather than an infection, sometimes blamed on bad air, heredity, or even excessive passion.
In the 18th and 19th centuries, consumption became romanticized in ways that seem bizarre today. The disease’s symptoms, pale skin, bright eyes, a slender frame, and flushed cheeks, overlapped with the era’s beauty ideals. Writers and poets including John Keats, the Brontë sisters, and Frédéric Chopin were among its most famous victims, and literary culture wrapped the disease in a gauze of tragic beauty. Dying of consumption could be portrayed as ethereal, spiritual, even glamorous, at least among the upper classes. For the poor, crammed into tenements and factories, there was nothing romantic about it.
The cultural impact of the disease extended beyond literature. The sanatorium movement of the late 19th and early 20th centuries, which we will get to shortly, directly influenced modernist architecture. Sanatoriums were designed with flat roofs, open balconies, terraces, and large windows to give patients maximum exposure to fresh air and sunlight. Those design principles bled into the broader modernist movement and shaped housing design well into the 20th century.4Medical History. What Tuberculosis did for Modernism: The Influence of a Curative Environment on Modernist Design and Architecture The clean lines and open spaces we associate with modern architecture owe a quiet debt to the disease once called consumption.
Koch Finds the Cause
For most of human history, TB was a mystery. People debated whether it was hereditary, environmental, or perhaps caused by some vague miasma. That changed on March 24, 1882, when the German physician Robert Koch presented his findings to the German Physiological Society in Berlin: tuberculosis was caused by a specific rod-shaped bacterium, which he had isolated using novel staining techniques and grown in culture.5PubMed Central. Robert Koch: From Anthrax to Tuberculosis – A Journey in Medical Science – Section: Understanding Tuberculosis: Koch’s Research, Treatment Trials, and the Introduction of Tuberculin Koch did not just identify the bacterium; he reproduced the disease by injecting it into guinea pigs, proving beyond doubt that this microbe was the cause.6PubMed. Steps towards the discovery of Mycobacterium tuberculosis by Robert Koch, 1882
Koch’s discovery was seismic. It turned consumption from a vague wasting condition into a specific, transmissible infection with a known enemy. It also triggered the search for diagnostic tools. Koch himself developed a substance called Old Tuberculin, which he initially hoped would treat the disease. It failed as a treatment, but its ability to provoke a skin reaction in infected individuals laid the groundwork for the tuberculin skin test, which in refined form is still used today.7PubMed Central. Latent tuberculosis testing through the ages: the search for a sleeping killer March 24 is now World Tuberculosis Day, commemorating Koch’s announcement.
How TB Actually Destroys the Lungs
Understanding why TB was called consumption requires understanding what the bacterium does once it takes hold. When you breathe in Mycobacterium tuberculosis, your immune system responds by walling off the bacteria inside structures called granulomas, clusters of immune cells surrounding a core of infected tissue. This response can contain the infection for years or even a lifetime, which is why most people exposed to TB never get sick. Roughly a quarter of the world’s population carries a latent TB infection that their immune system keeps in check.
But the granuloma is not a simple cage. It is a dynamic battleground. The bacteria can persist inside it, sometimes for decades, and the structure itself can become a site of tissue destruction. The necrotic core of a granuloma can liquefy, spilling bacteria into the airways and creating cavities in the lung.8European Respiratory Review. Tuberculosis and lung damage: from epidemiology to pathophysiology – Section: Mediators of lung damage and dysfunction in TB This is the process that produces the bloody cough, the weight loss, the slow wasting that gave the disease its old name. Research using animal models has shown that granulomas can actually help the bacteria spread rather than contain them, which challenges the older view of the granuloma as purely protective.9PubMed Central. The granuloma in tuberculosis: dynamics of a host-pathogen collusion
The Sanatorium Era
Before antibiotics existed, there was essentially no way to cure TB. What doctors could offer was management, and the primary institution for that was the sanatorium. From the mid-1800s through the mid-1900s, sanatoriums spread across Europe and North America. The philosophy was straightforward: fresh air, rest, nutritious food, and isolation from the general population. Patients were sent to mountain retreats or countryside facilities for months or years at a time. The approach had genuine public health value, even if it could not cure the disease, because isolating contagious patients reduced transmission.10PubMed Central. The history of tuberculosis: the social role of sanatoria for the treatment of tuberculosis in Italy between the end of the 19th century and the middle of the 20th
Treatments at sanatoriums ranged from benign to brutal. Alongside rest cures and outdoor walks, physicians used surgical interventions. The most common was artificial pneumothorax, in which air was deliberately injected into the space around the lung to collapse it. The idea was that resting the diseased lung would allow it to heal. This procedure was the most widely used collapse therapy throughout the pre-antibiotic era and remained standard sanatorium treatment for decades.11PubMed Central. Artificial pneumothorax: tapping into a small bit of history Other surgical approaches included removing ribs to permanently collapse part of the chest wall, or severing the nerve that controls the diaphragm. These were desperate measures for a disease with no pharmaceutical answer.
The BCG Vaccine
The only TB vaccine the world has ever had is BCG, short for Bacille Calmette-Guérin, named after the two French scientists who developed it. Albert Calmette and Camille Guérin spent years weakening a strain of bovine tuberculosis bacterium until it could no longer cause disease but could still provoke an immune response. The vaccine was first used in humans in 1921 and has since been administered to billions of people worldwide.12PubMed Central. History of BCG Vaccine
BCG is a peculiar vaccine by modern standards. It is highly effective at preventing severe forms of TB in children, particularly the disseminated and meningeal types that can be rapidly fatal. But its protection against pulmonary TB in adults is inconsistent, varying widely depending on geography, the strain of BCG used, and other factors that researchers still argue about. Despite this limitation, BCG remains one of the most widely given vaccines in the world and has significantly reduced child mortality in high-burden regions.13PubMed Central. BCG vaccination: historical role, modern applications, and future perspectives in tuberculosis and beyond The search for a better TB vaccine has been underway for decades but has yet to produce a licensed replacement.
The Antibiotic Revolution
The real turning point in the fight against TB came with streptomycin, discovered by Selman Waksman’s laboratory and first used against tuberculosis in the 1940s. Waksman would receive the 1952 Nobel Prize for the discovery of what was the first antibiotic effective against TB.14PubMed. Selman A. Waksman (1888-1973) Nobel Prize in 1952 for the discovery of streptomycin, the first antibiotic effective against tuberculosis The 1948 Medical Research Council trial of streptomycin in pulmonary TB is also historically significant as the first randomized controlled trial in the modern sense, a landmark in clinical medicine as well as in TB treatment.15PubMed Central. The MRC randomized trial of streptomycin and its legacy: a view from the clinical front line
Streptomycin was transformative, but it had a critical flaw: when used alone, TB bacteria quickly developed resistance to it. This hard lesson led to one of the most important principles in TB treatment. In 1950, the UK’s Medical Research Council documented the first successful use of combination therapy, pairing streptomycin with para-aminosalicylic acid.16PubMed Central. Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application The principle stuck: modern standard treatment for drug-susceptible TB uses a minimum of four antibiotics over six months. The regimen is effective but demanding, requiring patients to take pills daily for half a year, often under direct observation to ensure adherence.
Through the mid-20th century, antibiotics combined with public health measures drove TB rates down dramatically in wealthy countries. Sanatoriums closed. TB began to feel like a conquered disease, at least in Europe and North America. That sense of victory would prove premature.
HIV and the Resurgence of TB
Two developments shattered the complacency of the late 20th century. The first was the HIV/AIDS epidemic. HIV and TB form a lethal partnership: HIV infection increases the risk of developing active TB roughly sevenfold, and people carrying both infections develop active TB disease at a rate of 5 to 10 percent per year, compared with a 5 to 10 percent lifetime risk for someone with TB alone.17PubMed. Resurgence of tuberculosis and the impact of HIV infection In sub-Saharan Africa, where both diseases are concentrated, the combination has been devastating. In 2024, an estimated 620,000 people living with HIV developed TB, and roughly 150,000 of them died from it.18The Lancet Microbe. State of the global tuberculosis epidemic: burden, progress towards WHO End TB Strategy targets and systemic challenges
The second crisis was drug resistance. Weak health systems, incomplete treatment courses, and substandard medications allowed resistant strains of TB to emerge and spread. Multidrug-resistant TB, which does not respond to the two most powerful first-line drugs, and extensively drug-resistant TB, which resists even some second-line drugs, are now present in virtually every country.19PubMed Central. Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis Treating drug-resistant TB requires longer courses of more toxic, more expensive medications. Until recently, cure rates for the worst forms were dismal. The approval of new drugs like bedaquiline, the first novel class of TB drug in decades, has improved the outlook for resistant cases, though cardiac side effects require careful monitoring.20PubMed. QT Prolongation Associated with Administration of Bedaquiline, a Novel Anti-Tuberculosis Drug
The Animal Connection
While Mycobacterium tuberculosis is a human-adapted pathogen, a close relative called Mycobacterium bovis causes tuberculosis in cattle and can jump to people. The main route of transmission is through unpasteurized milk.21PubMed. Prevalence of Mycobacterium bovis in milk on dairy cattle farms: An international systematic literature review and meta-analysis Before pasteurization became routine in wealthy countries, bovine TB was a significant source of human disease, particularly in children who drank raw milk. In much of the developing world, where pasteurization is not universal and cattle herds may not be tested, this remains a genuine public health concern. It is also a reminder that the older assumption about TB jumping from cattle to humans was not entirely wrong; it was just the wrong species of the bacterium. Mycobacterium bovis can infect people, but the strain responsible for the vast majority of human TB evolved alongside us independently.
TB Today and the Weight It Places on Patients
Tuberculosis is sometimes discussed as though it belongs to history, but it killed an estimated 1.23 million people in 2024, making it the leading infectious disease killer worldwide in most recent years, alternating with COVID-19 for that grim distinction.18The Lancet Microbe. State of the global tuberculosis epidemic: burden, progress towards WHO End TB Strategy targets and systemic challenges Roughly 10.7 million people developed the disease that year. The WHO’s End TB Strategy set ambitious targets for reducing incidence and mortality, but progress has been slow and was set back further by the COVID-19 pandemic, which disrupted TB diagnosis and treatment programs worldwide.22European Respiratory Review. Tuberculosis: current challenges and beyond – Section: The End TB Strategy
One dimension of the crisis that rarely makes headlines is the financial devastation TB inflicts on patients and their families. A meta-regression across low- and middle-income countries estimated that the average patient spends about $1,253 per episode of TB, with indirect costs like lost income making up the largest share.23PubMed Central. Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: a meta-regression analysis – Section: INTERPRETATION That may sound modest by wealthy-country standards, but in the communities where TB is most common, it can represent half a household’s annual income or more. A meta-analysis found that roughly 43 percent of TB-affected families face catastrophic costs, defined as spending more than 20 percent of their annual pre-TB household income on the disease. For drug-resistant TB or TB-HIV co-infection, that figure rises to about 81 percent.24PubMed Central. A systematic review and meta-analysis of the catastrophic costs incurred by tuberculosis patients The WHO set a target of zero percent catastrophic costs by 2020, a target that was not met and remains far off. TB is a disease of poverty that deepens poverty, creating a cycle that pure medical treatment alone cannot break.
Why “the Consumption” Still Matters as a Name
The old name for tuberculosis carries information that the clinical label does not. It tells you what the disease looked like from the outside, before microscopes and X-rays, when the only diagnostic tool was watching someone slowly disappear. It captures the experience of families who watched a relative grow pale, lose weight, and cough themselves to death over months or years with no treatment available. And it connects the modern disease to a cultural history that stretches from Keats to sanatorium architecture to the public health campaigns that reshaped cities.
The term fell out of common use in the early 20th century as Koch’s bacteriological understanding replaced the older clinical vocabulary. “Tuberculosis,” derived from the Latin word for the small nodules (tubercles) the disease creates in lung tissue, became the standard. But “consumption” lingered in everyday speech for decades afterward, and its echo survives in period literature, family histories, and the death records of millions. If you have ancestors from the 19th century or earlier, there is a reasonable chance one of them appears in a record as having died of consumption. Now you know what killed them, and how long the bacterium behind it had been waiting.